These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma. Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483 [TBL] [Abstract][Full Text] [Related]
4. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cells infected with recombinant adenoviral vector encoding mouse fibroblast activation protein-α and human livin α exert an antitumor effect against Lewis lung carcinoma in mice. Ye Z; Pan J; Yin Z; Wang S; Li Y; Cai X; Zheng H; Cao Z Immun Inflamm Dis; 2023 Sep; 11(9):e1011. PubMed ID: 37773704 [TBL] [Abstract][Full Text] [Related]
6. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma. Ho MY; Sun GH; Leu SJ; Ka SM; Tang SJ; Sun KH Int J Cancer; 2008 Jul; 123(1):123-33. PubMed ID: 18386791 [TBL] [Abstract][Full Text] [Related]
7. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]. You J; Wang CL; Hao XS Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273 [TBL] [Abstract][Full Text] [Related]
8. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma. Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684 [TBL] [Abstract][Full Text] [Related]
10. Antitumor immunity targeting fibroblast activation protein-α in a mouse Lewis lung carcinoma model. Xie J; Yuan S; Peng L; Li H; Niu L; Xu H; Guo X; Yang M; Duan F Oncol Lett; 2020 Jul; 20(1):868-876. PubMed ID: 32566014 [TBL] [Abstract][Full Text] [Related]
11. Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses. Zheng H; Liu L; Zhang H; Kan F; Wang S; Li Y; Tian H; Meng S PLoS One; 2019; 14(1):e0211490. PubMed ID: 30703157 [TBL] [Abstract][Full Text] [Related]
12. TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells. Narusawa M; Inoue H; Sakamoto C; Matsumura Y; Takahashi A; Inoue T; Watanabe A; Miyamoto S; Miura Y; Hijikata Y; Tanaka Y; Inoue M; Takayama K; Okazaki T; Hasegawa M; Nakanishi Y; Tani K Cancer Immunol Res; 2014 Jun; 2(6):568-80. PubMed ID: 24830413 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells engineered to express GITRL enhance therapeutic immunity in murine Lewis lung carcinoma. Ma J; Wang S; Ma B; Mao C; Tong J; Yang M; Wu C; Jiao Z; Lu L; Xu H Cancer Lett; 2011 Feb; 301(2):142-50. PubMed ID: 21186078 [TBL] [Abstract][Full Text] [Related]
14. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells. Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812 [TBL] [Abstract][Full Text] [Related]
15. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide]. Zhang W; He L; Cao X Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032 [TBL] [Abstract][Full Text] [Related]
16. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo. Peng W; Zhao G; Ma Y; Yu H; Wang X Vaccine; 2011 Apr; 29(18):3501-6. PubMed ID: 21352943 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells. Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800 [TBL] [Abstract][Full Text] [Related]
19. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Tillman BW; Hayes TL; DeGruijl TD; Douglas JT; Curiel DT Cancer Res; 2000 Oct; 60(19):5456-63. PubMed ID: 11034088 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice. Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]